IL7 and myeloid sarcoma: In vitro functional experiments further confirmed that IL‐7 stimulation can significantly amplify the IL‐17 secretion level of MAIT cells in patients with MS and promote the expression of RORγt (a core transcription factor of Th17 cells) and CCR6 (a characteristic chemokine receptor of Th17 cells).